Swiss Life Sciences Stock News

Why R&S Group Holding’s latest guidance and dividend decision matter R&S Group Holding (SWX:RSGN) has set fresh expectations for FY2025, pairing new earnings guidance for organic net sales growth of 8 to 12% over the cycle with a confirmed proposed dividend of CHF 0.50 per share. For you as an investor, this combination of quantified growth ambitions and a specific cash payout level provides clearer signals on how management is thinking about balancing reinvestment in the business with direct...

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Firstly...

Chocoladefabriken Lindt & Sprüngli (SWX:LISN) is back in focus after reintroducing its DubaiStyle Chocolate to Canadian shelves and adding a new 40g snack bar, highlighting ongoing product momentum. See our latest analysis for Chocoladefabriken Lindt & Sprüngli. The latest DubaiStyle Chocolate relaunch comes as Chocoladefabriken Lindt & Sprüngli’s 1 month share price return of 7.83% and year to date share price return of 7.64% contrast with a flat 3 month period. At the same time, a 1 year...

Banque Cantonale Vaudoise (SWX:BCVN) has released its full year 2025 earnings, reporting net interest income of CHF 529 million and net income of CHF 429.7 million, both lower than the prior year. See our latest analysis for Banque Cantonale Vaudoise. Despite the softer 2025 earnings, Banque Cantonale Vaudoise’s share price has climbed to CHF110.9, with a 30 day share price return of 9.8% and a 1 year total shareholder return of 23.61%. This suggests recent momentum alongside solid long term...

Novartis (SWX:NOVN) has signed a new long term supply agreement with Niowave Inc. for Actinium 225, an isotope used in radioligand cancer therapies. The deal is aimed at supporting Novartis's expanding oncology portfolio and addressing the global shortage of Actinium 225. Niowave plans to increase production capacity to meet Novartis's needs under the agreement. For investors tracking Novartis at a current share price of CHF123.8, this move ties directly into the company’s focus on oncology...

Why Schindler Holding’s latest earnings matter for shareholders Schindler Holding (SWX:SCHN) has put fresh numbers on the table, reporting a 2025 EBIT margin of 12.6%, stronger modernization activity, and a proposed mix of regular and extraordinary dividends that directly affects shareholder cash returns. See our latest analysis for Schindler Holding. At a share price of CHF273.0, Schindler Holding has seen a 2.63% 1 day share price return after the earnings release, even though the 7 day...

Analyst attention and new product launch put Alcon in focus Alcon (SWX:ALC) has come into the spotlight after RBC Capital and BTIG reiterated positive views and William Blair began coverage, shortly after the company announced its PRECISION7 weekly replacement contact lenses in Canada. See our latest analysis for Alcon. Despite the recent analyst attention and the PRECISION7 launch, Alcon’s 1 year total shareholder return decline of 25.77% and 5 year total shareholder return decline of 4.19%...

The board of Swiss Prime Site AG ( VTX:SPSN ) has announced that it will be paying its dividend of CHF3.50 on the 31st...

Investors in ams-OSRAM AG ( VTX:AMS ) had a good week, as its shares rose 7.9% to close at CHF8.78 following the...

It's not a stretch to say that Romande Energie Holding SA's ( VTX:REHN ) price-to-sales (or "P/S") ratio of 1.4x right...

If you are wondering whether Nestlé at around CHF79.34 is offering fair value or a potential bargain, you are in the right place for a clear look at what that price really represents. The stock has returned 1.2% over the last 7 days and 5.5% over the last 30 days, although the 1 year return is a 1.8% decline and the 3 year return sits at a 19.3% decline, with a 7.9% decline over 5 years. Recent coverage has focused on how investors are reassessing large consumer staples companies like...

St. Galler Kantonalbank (SWX:SGKN) just posted its FY 2025 first half results with total revenue of CHF295.4 million and net income of CHF114.1 million, while trailing twelve month revenue sits at CHF589.7 million and net income at CHF227.0 million. The bank has seen revenue move from CHF268.5 million in the first half of 2024 to CHF279.97 million in the second half and then to CHF295.4 million in the latest half, with trailing twelve month net income rising from CHF215.1 million to CHF227.0...

Comet Holding (SWX:COTN) is back in focus after reports of stronger demand for its semiconductor and inspection equipment, particularly RF and X-ray products tied to AI uses, with a closely watched earnings date approaching. See our latest analysis for Comet Holding. Comet Holding’s recent 20.0% 1 month share price return and 49.7% 3 month share price return, with the stock now at CHF287.8, points to building momentum. At the same time, the 5 year total shareholder return of 37.4% shows more...

DKSH Holding (SWX:DKSH) heads into its 17 February 2026 earnings release with investors closely watching margins in Healthcare and Consumer Goods, alongside working capital metrics that could influence dividend expectations and near term sentiment. See our latest analysis for DKSH Holding. At a share price of CHF60.8, DKSH Holding has a 90 day share price return of 10.34%. Its 1 year total shareholder return of 10.59% and 3 year total shareholder return of 14.65% suggest recent momentum...

Sika (SWX:SIKA) is back in focus after opening five new manufacturing sites across the United States, Argentina, Colombia, Bangladesh, and Tanzania. This broad capacity buildout tightens its supply chain for construction materials. See our latest analysis for Sika. Despite this global buildout and the relaunch of its technical training program, Sika’s CHF157.5 share price sits against a 1-year total shareholder return of a 31.7% decline and a 5-year total shareholder return of a 33.1%...

While Siegfried Holding AG ( VTX:SFZN ) might not have the largest market cap around , it led the SWX gainers with a...

If you are wondering whether UBS Group shares still offer value at current levels, you are not alone. This article is designed to help you weigh that up clearly. The stock last closed at CHF32.57, with returns of a 6.4% decline over 7 days, a 14.2% decline over 30 days and a 14.7% decline year to date, while the 1 year return sits at 12% and the 3 and 5 year returns are 74.5% and 166.5% respectively. Recent coverage has focused on UBS Group's role as a major global wealth manager and...

If you are wondering whether Julius Bär Gruppe’s current share price offers solid value or not, it helps to first step back and frame what the recent returns are actually telling you. The stock last closed at CHF63.74, with a 7 day return of a 5.3% decline, a 30 day return of a 1.9% decline, a year to date return of a 3.1% decline, but a 16.3% gain over 1 year, 20.4% over 3 years and 47.6% over 5 years. These mixed short term and longer term returns have kept interest in Julius Bär Gruppe...

Georg Fischer AG ( VTX:GF ), might not be a large cap stock, but it saw significant share price movement during recent...

Key Insights Significant control over dormakaba Holding by individual investors implies that the general public has...

The board of Vontobel Holding AG ( VTX:VONN ) has announced that it will pay a dividend on the 20th of April, with...

To the annoyance of some shareholders, WISeKey International Holding AG ( VTX:WIHN ) shares are down a considerable 25...

Why fenebrutinib and data analytics matter for Roche Holding stock Roche Holding (SWX:ROG) has put fresh attention on its pipeline after reporting late stage data for its oral MS candidate fenebrutinib and highlighting new data analytics platforms in clinical development. For you as a shareholder or potential investor, these updates link directly to how Roche allocates R&D spending, manages clinical risk and builds potential future revenue sources beyond its currently marketed therapies. See...

Earnings setback and dividend affirmation come into focus Swatch Group (SWX:UHR) is in the spotlight after full year 2025 results showed sales of CHF 6,280 million and net income of CHF 3 million, alongside confirmation of an annual dividend of CHF 4.50 per share. See our latest analysis for Swatch Group. The annual results and dividend affirmation arrived alongside strong near term momentum, with a 1 day share price return of 2.43% and a 30 day share price return of 12.53%. However, the 3...